Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Guaraldi

Showing results (371-380 of 408) with videos related to

Pageof 41
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapyAndrea Antinori, Dora Larussa, Antonella Cingolani, et al.
HIV Medicine|March 26, 2022
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021Lene Ryom, Rosa De Miguel, Aoife Grace Cotter, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 3, 2022
Characteristics of long-COVID among older adults: a cross-sectional studyVered Daitch, Dana Yelin, Muhammad Awwad, et al.
The Lancet. HIV|May 2, 2025
Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular diseaseJasmini Alagaratnam, Kathrin van Bremen, Georg M N Behrens, et al.
Nature Communications|May 11, 2021
Identification and characterization of a SARS-CoV-2 specific CD8<sup>+</sup> T cell response with immunodominant featuresAnastasia Gangaev, Steven L C Ketelaars, Olga I Isaeva, et al.
Plos One|February 23, 2021
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infectionCristina Mussini, Alessandro Cozzi-Lepri, Marianna Menozzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2022
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized TrialLaura Waters, Lambert Assoumou, Ana González-Cordón, et al.
Communications Biology|June 17, 2022
Molecular and cellular immune features of aged patients with severe COVID-19 pneumoniaDomenico Lo Tartaro, Anita Neroni, Annamaria Paolini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2023
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 TrialAbiu Sempere, Lambert Assoumou, Ana González-Cordón, et al.
Viruses|February 28, 2023
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort StudyCristina Mussini, Alessandro Cozzi-Lepri, Marianna Meschiari, et al.
Pageof 41

Showing results (371-380 of 408) with videos related to

Sort By:
Pageof 41
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapyAndrea Antinori, Dora Larussa, Antonella Cingolani, et al.
HIV Medicine|March 26, 2022
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021Lene Ryom, Rosa De Miguel, Aoife Grace Cotter, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 3, 2022
Characteristics of long-COVID among older adults: a cross-sectional studyVered Daitch, Dana Yelin, Muhammad Awwad, et al.
The Lancet. HIV|May 2, 2025
Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular diseaseJasmini Alagaratnam, Kathrin van Bremen, Georg M N Behrens, et al.
Nature Communications|May 11, 2021
Identification and characterization of a SARS-CoV-2 specific CD8<sup>+</sup> T cell response with immunodominant featuresAnastasia Gangaev, Steven L C Ketelaars, Olga I Isaeva, et al.
Plos One|February 23, 2021
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infectionCristina Mussini, Alessandro Cozzi-Lepri, Marianna Menozzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2022
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized TrialLaura Waters, Lambert Assoumou, Ana González-Cordón, et al.
Communications Biology|June 17, 2022
Molecular and cellular immune features of aged patients with severe COVID-19 pneumoniaDomenico Lo Tartaro, Anita Neroni, Annamaria Paolini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2023
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 TrialAbiu Sempere, Lambert Assoumou, Ana González-Cordón, et al.
Viruses|February 28, 2023
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort StudyCristina Mussini, Alessandro Cozzi-Lepri, Marianna Meschiari, et al.
Pageof 41